Christina Mangurian1, Francine Cournos1, Dean Schillinger1, Eric Vittinghoff1, Jennifer M Creasman1, Bernard Lee1, Penelope Knapp1, Elena Fuentes-Afflick1, James W Dilley1. 1. Dr. Mangurian, Mr. Lee, and Dr. Dilley are with the Department of Psychiatry and the Weill Institute for Neurosciences; Dr. Schillinger is with the Department of Medicine; Dr. Vittinghoff is with the Department of Epidemiology and Biostatistics; Ms. Creasman is with the Clinical and Translational Science Institute (CTSI); and Dr. Fuentes-Afflick is with the Department of Pediatrics, all at the School of Medicine, University of California, San Francisco (UCSF) (e-mail: christina.mangurian@ucsf.edu ). Dr. Mangurian, Dr. Schillinger, Dr. Fuentes-Afflick, and Dr. Dilley are also with Zuckerberg San Francisco General Hospital, San Francisco. Dr. Cournos is with the Department of Psychiatry, Columbia University, New York City. Dr. Knapp is with the Department of Psychiatry and Behavioral Sciences, University of California, Davis.
Abstract
OBJECTIVE: This research aimed to characterize HIV testing rates among Medicaid recipients with severe mental illness who received public specialty mental health services. METHODS: This retrospective cohort study examined California Medicaid records from October 1, 2010, to September 30, 2011 (N=56,895). Study participants were between age 18 and 67, utilized specialty mental health care services, were prescribed antipsychotic medications, and were not dually eligible for Medicare. Adjusted Poisson regression models were used to estimate the overall effects of predictor variables on HIV testing prevalence. RESULTS: During the study period, 6.7% of people with severe mental illness received HIV testing. Men were 32% less likely to be tested for HIV than women (p<.001). Compared with whites, Asians/Pacific Islanders were 53% less likely and blacks were 82% more likely to be tested (p<.001). Those with comorbid drug or alcohol use disorders were more likely to be tested than those without such disorders (p<.001). Utilization of nonpsychiatric medical care was the strongest predictor of HIV testing (p<.001). CONCLUSIONS: Most adults with severe mental illness receiving public specialty mental health services were not tested for HIV during a one-year period. Public health administrators must prioritize HIV testing for early identification of HIV infection and prevention of HIV transmission.
OBJECTIVE: This research aimed to characterize HIV testing rates among Medicaid recipients with severe mental illness who received public specialty mental health services. METHODS: This retrospective cohort study examined California Medicaid records from October 1, 2010, to September 30, 2011 (N=56,895). Study participants were between age 18 and 67, utilized specialty mental health care services, were prescribed antipsychotic medications, and were not dually eligible for Medicare. Adjusted Poisson regression models were used to estimate the overall effects of predictor variables on HIV testing prevalence. RESULTS: During the study period, 6.7% of people with severe mental illness received HIV testing. Men were 32% less likely to be tested for HIV than women (p<.001). Compared with whites, Asians/Pacific Islanders were 53% less likely and blacks were 82% more likely to be tested (p<.001). Those with comorbid drug or alcohol use disorders were more likely to be tested than those without such disorders (p<.001). Utilization of nonpsychiatric medical care was the strongest predictor of HIV testing (p<.001). CONCLUSIONS: Most adults with severe mental illness receiving public specialty mental health services were not tested for HIV during a one-year period. Public health administrators must prioritize HIV testing for early identification of HIV infection and prevention of HIV transmission.
Entities:
Keywords:
AIDS; Community mental health services; Quality of care; Research/service delivery; Schizophrenia
Authors: Christina Mangurian; Marilyn D Thomas; Fumi Mitsuishi; L Elizabeth Goldman; Grace Niu; Margaret A Handley; Nicholas S Riano; Alison Hwong; Susan Essock; James Dilley; John W Newcomer; Dean Schillinger Journal: Psychiatr Serv Date: 2022-02-09 Impact factor: 4.157
Authors: Evan A Krueger; Ian W Holloway; Marguerita Lightfoot; Andy Lin; Phillip L Hammack; Ilan H Meyer Journal: LGBT Health Date: 2020-04-16 Impact factor: 4.151
Authors: Martha Shumway; Christina Mangurian; Noah Carraher; Amanda Momenzadeh; Mark Leary; Emily K Lee; James W Dilley Journal: Psychosomatics Date: 2017-10-23 Impact factor: 2.386
Authors: Helene J Smith; Stephanie M Topp; Christopher J Hoffmann; Thulani Ndlovu; Salome Charalambous; Laura Murray; Jeremy Kane; Izukanji Sikazwe; Monde Muyoyeta; Michael E Herce Journal: Curr HIV/AIDS Rep Date: 2020-10 Impact factor: 5.071
Authors: Matthew L Goldman; Christina Mangurian; Tom Corbeil; Melanie M Wall; Fei Tang; Morgan Haselden; Susan M Essock; Eric Frimpong; Franco Mascayano; Marleen Radigan; Matthew Schneider; Rui Wang; Lisa B Dixon; Mark Olfson; Thomas E Smith Journal: Gen Hosp Psychiatry Date: 2020-06-23 Impact factor: 3.238
Authors: Nicholas S Riano; Hannah M Borowsky; Emily A Arnold; Mark Olfson; James T Walkup; Eric Vittinghoff; Francine Cournos; Lindsey Dawson; Alexander R Bazazi; Stephen Crystal; Christina Mangurian Journal: Psychiatr Serv Date: 2021-06-15 Impact factor: 3.084
Authors: Matthew A Spinelli; Hyman M Scott; Eric Vittinghoff; Albert Y Liu; Rafael Gonzalez; Alicia Morehead-Gee; Monica Gandhi; Susan P Buchbinder Journal: Open Forum Infect Dis Date: 2019-02-26 Impact factor: 3.835
Authors: Jordan J White; Nickolas D Zaller; M Isabel Fernandez; Pilgrim Spikes; Stephen Flores; Carl A Latkin; Cui Yang Journal: Community Ment Health J Date: 2021-07-03